肥胖对流感的影响 疫苗免疫性:系统性审查
Michelle Clarke1, Mark McMillan1, Lynne C Giles2
1Women's and Children's Health Network, North Adelaide, SA 5006, Australia; The Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, SA 5005, Australia.
Vaccine
|October 1, 2025
概括
肥胖不会对流感疫苗的有效性产生负面影响. 研究表明,肥胖患者在接种疫苗后一个月可能有增强的抗体反应,可能是由于其炎症特征.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 流感对健康构成重大风险,特别是在高风险人群中.
- 肥胖与流感严重程度的增加有关,是疫苗接种策略的关键考虑因素.
- 与肥胖相关的炎症特征可能会影响疫苗免疫性.
研究的目的:
- 系统地审查现有的关于肥胖和流感疫苗免疫性之间的联系的研究.
- 评估疫苗接种后肥胖与非肥胖个体的血清保护和血清转化率.
主要方法:
- 一项对比肥胖和非肥胖个体流感疫苗反应的研究的系统审查和元分析.
- 在PubMed,Embase和Scopus数据库中进行的搜索,由两个独立审核员进行数据提取和评估.
- 在 Stata 17 中使用随机效应模型进行的元分析.
主要成果:
- 涉及儿童和成人 (包括孕妇) 的11项研究符合纳入标准.
- 肥胖与A/H1N1流感菌株的血清转化和血清保护率略高相关.
- 在A/H3N2菌株中观察到较高的血清转化率,而在B型流感菌株中没有显著差异.
结论:
- 肥胖患者的流感疫苗接种免疫力在接种疫苗后一个月没有受到影响.
- 肥胖可能与对流感疫苗的抗体反应增强有关.
- 肥胖症的炎症性免疫特征可能有助于这些增强的疫苗反应.
相关概念视频
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Vaccinations
51.3K
Overview
51.3K
Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K


